In vitro antibacterial, antifungal and cytotoxic activities of some triazole Schiff bases and their oxovanadium(IV) complexes

References

• Klingele MH, Brooker S. The coordination chemistry of 4-substituted 3,5-di(2-pyridyl)-4H-1,2,4-triazoles and related ligands. Coord Chem Rev 2003;241:119–132.
   Web of Science ®Google Scholar
• Tarzia G, Occelli E, Toja E, Barone D, Corsico N, Gallico L et al. 6-(Alkylamino)-3-aryl-1,2,4-triazolo[3,4-a]phthalazines. A new class of benzodiazepine receptor ligands. J Med Chem 1988;31:1115–1123.
   PubMed Web of Science ®Google Scholar
• Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007;356:348–359.
   PubMed Web of Science ®Google Scholar
• Bagihalli GB, Avaji PG, Patil SA, Badami PS. Synthesis, spectral characterization, in vitro antibacterial, antifungal and cytotoxic activities of Co(II), Ni(II) and Cu(II) complexes with 1,2,4-triazole Schiff bases. Eur J Med Chem 2008;43:2639–2649.
   PubMed Web of Science ®Google Scholar
• Rezaei Z, Khabnadideh S, Pakshir K, Hossaini Z, Amiri F, Assadpour E. Design, synthesis, and antifungal activity of triazole and benzotriazole derivatives. Eur J Med Chem 2009;44:3064–3067.
   PubMed Web of Science ®Google Scholar
• Cui XS, Jing C, Chai KY, Lee JS, Quan ZS. Synthesis and anticonvulsant evaluation of 3-substituted-4-(4-hexyloxyphenyl)-4H-1,2,4-triazoles. Med Chem Res 2009;18:49–58.
   Web of Science ®Google Scholar
• Manfredini S, Vicentini CB, Manfrini M, Bianchi N, Rutigliano C, Mischiati C et al. Pyrazolo-triazoles as light activable DNA cleaving agents. Bioorg Med Chem 2000;8:2343–2346.
   PubMed Web of Science ®Google Scholar
• Romagnoli R, Baraldi PG, Cruz-Lopez O, Lopez Cara C, Carrion MD, Brancale A et al. Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues. J Med Chem 2010;53:4248–4258.
   PubMedGoogle Scholar
• Kaplancikli ZA, Turan-Zitouni G, Chevallet P. Synthesis and antituberculosis activity of new 3-alkylsulfanyl-1,2,4-triazole derivatives. J Enzyme Inhib Med Chem 2005;20:179–182.
   PubMed Web of Science ®Google Scholar
• Shivarama Holla B, Veerendra B, Shivananda MK, Poojary B. Synthesis characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles. Eur J Med Chem 2003;38:759–767.
   PubMed Web of Science ®Google Scholar
• Akhtar T, Hameed S, Al-Masoudi NA, Khan KM. Synthesis, and anti-HIV activity of new chiral 1,2,4-triazoles and 1,3,4-thiadiazoles. Heteroatom Chem 2007;18:316–322.
   Web of Science ®Google Scholar
• Holla BS, Akberali PM, Shivananda MK. Studies on nitrophenylfuran derivatives part Xii. synthesis, characterization, antibacterial and antiviral activities of some nitrophenylfurfurylidene-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines. Farmaco 2001;56:919–927.
   PubMedGoogle Scholar
• Muhammad N, Ali S, Shahzadi S, Khan AN. Oxovanadium(IV) complexes of non-steroidal anti-inflammatory drugs: Synthesis, spectroscopy, and antimicrobial activity. Russ J Coord Chem 2008;34:448–453.
   Web of Science ®Google Scholar
• Noblía P, Vieites M, Parajón-Costa BS, Baran EJ, Cerecetto H, Draper P et al. Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): Crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)]. J Inorg Biochem 2005;99:443–451.
   PubMed Web of Science ®Google Scholar
• Dong Y, Narla RK, Sudbeck E, Uckun FM. Synthesis, X-ray structure, and anti-leukemic activity of oxovanadium(IV) complexes. J Inorg Biochem 2000;78:321–330.
   PubMed Web of Science ®Google Scholar
• D’Cruz OJ, Dong Y, Uckun FM. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2′-bipyridyl, 5′-bromo-2′-hydroxyacetophenone and derivatives in humans. Biol Reprod 1999;60:435–444.
   PubMed Web of Science ®Google Scholar
• Maurya MR, Agarwal S, Abid M, Azam A, Bader C, Ebel M et al. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes. Dalton Trans 2006;937–947.
   PubMedGoogle Scholar
• Etcheverry SB, Ferrer EG, Naso L, Rivadeneira J, Salinas V, Williams PA. Antioxidant effects of the VO(IV) hesperidin complex and its role in cancer chemoprevention. J Biol Inorg Chem 2008;13:435–447.
   PubMed Web of Science ®Google Scholar
• Evelina GF, Salinas MV, Correa MJ, Luciana N, Barrio DA, Etcheverry SB et al. Synthesis, characterization, antitumoral and osteogenic activities of quercetin vanadyl(IV) complexes. J Biol Inorg Chem 2006;11:791–801.
   PubMedGoogle Scholar
• Sakurai H, Kojitane Y, Yoshikawa Y, Kawabe K, Yasui H. Antidiabetic vanadium(IV) and zinc(II) complexes. Coord Chem Rev 2002;226:187–189.
   Web of Science ®Google Scholar
• Maurya RC, Mishra DD, Pillai V. Synthesis and characterization of some mixed-ligand thiocyanato complexes of cadmium(ii), mercury(ii), zinc(II) with 2-or 3-pyrazoline-5-one derivatives. Synth React Inorg Met-Org Chem 1995;25:139–150.
   Google Scholar
• Chohan ZH, Sumrra SH, Youssoufi MH, Hadda TB. Metal based biologically active compounds: Design, synthesis, and antibacterial/antifungal/cytotoxic properties of triazole-derived Schiff bases and their oxovanadium(IV) complexes. Eur J Med Chem 2010;45:2739–2747.
   PubMed Web of Science ®Google Scholar
• Guennouna L, Eljastimi J, Guediraa F, Marakchi K, Kabbaj OK, El Hajji A et al. Molecular geometry and vibrational studies of 3,5-diamino-1,2,4-triazole using quantum chemical calculations and FT-IR and FT-Raman spectroscopies. Spectrochimica Acta Part A 2011;78:347–353.
   PubMedGoogle Scholar
• Bagihalli GB, Badami PS, Patil SA. Synthesis, spectral characterization and in vitro biological studies of Co(II), Ni(II) and Cu(II) complexes with 1,2,4-triazole Schiff bases. J Enzyme Inhib Med Chem 2009;24:381–394.
   PubMed Web of Science ®Google Scholar
• Chohan ZH, Hanif M. Design, synthesis, and biological properties of triazole derived compounds and their transition metal complexes. J Enzyme Inhib Med Chem 2010;25:737–749.
   PubMed Web of Science ®Google Scholar
• Maurya RC, Singh H, Pandey A. Oxovanadium(IV) complexes of bioinorganic and industrial relevance: Synthesis and characterization of some oxovanadium(IV) complexes involving schiff bases derived from biologically active 4-benzoyl-3-methyl-1-phenyl-2-pyrazolin-5-one and certain aromatic amines. Synth React Inorg Met-Org Chem 2002;32:231–246.
   Web of Science ®Google Scholar
• Xie M, Gao L, Li L, Liu W, Yan S. A new orally active antidiabetic vanadyl complex–bis(alpha-furancarboxylato)oxovanadium(IV). J Inorg Biochem 2005;99:546–551.
   PubMed Web of Science ®Google Scholar
• Chernyshev VM, Rakitov VA, Astakhov AV, Sokolov AN, Zemlyakov ND, Taranushich VA. Regioselective synthesis of alkyl derivatives of 3,5-diamino-1,2,4-triazole. Russ J Appl Chem 2006;79:624–630.
   Google Scholar
• Agarwal RK, Singh L, Sharma DK, Singh R. Synthesis, spectral and thermal investigations of some oxovanadium(iv) complexes of hydrazones of isonicotinic acid hydrazide. Turk J Chem 2005;29:309–316.
   Web of Science ®Google Scholar
• Raman N, Raja JD, Sakthivel A. Design, synthesis, spectroscopic characterization, biological screening, and DNA nuclease activity of transition metal complexes derived from a tridentate Schiff base. Russ J Coord Chem 2008;34:400–406.
   Web of Science ®Google Scholar
• Chohan ZH, Sumrra SH. Synthesis, characterization and biological properties of thienyl derived triazole Schiff bases and their oxovanadium(IV) complexes. J Enzyme Inhib Med Chem 2012;27:187–193.
   PubMed Web of Science ®Google Scholar